Munger Pavilion / National Cancer Institute / Laboratory of Human Carcinogenesis / New York Medical College / Westchester Medical Center / Maria Fareri Children’s Hospital / /
IndustryTerm
treatment of potentially lethal diseases / /
MedicalCondition
hepatic fibrosis / leukemia / megakaryoblastic leukemia / lethal diseases / Down’s syndrome / minimal residual disease / cancer / GATA1-mutations Patient Mutation* Protein Cancer / disease / Down syndrome Sharon R. Pine / myelodysplastic syndrome / myeloproliferative syndrome / acute megakaryoblastic leukemia / transient leukemia / childhood leukemia / ANOVA test. 储One patient developed leukemia / trisomy 21 / transient myeloproliferative disorder / Pediatr Blood Cancer / Subsequent leukemia / Frameshift Unspecified leukemia / acute megakaryoblastic leukemia accompanying Down syndrome / acute myeloid leukemia / transient myeloid disorder / Down syndrome / /
MusicGroup
C.M. / /
Organization
National Cancer Institute / New York State Department / United States Census Bureau / Division of Hematology/Oncology / National Center for Biotechnology Information / Human Genome Variation Society / American Society of Hematology / Children’s Cancer Fund / U.S. Census Bureau / New York Medical College / Laboratory of Human Carcinogenesis / Maria Fareri Children’s Hospital / American Society of Hematology Introduction / /
Person
Sharon R. Pine / Maria J. Schymura / John D. Crispino / Doyle J. Leukemia / Amy R. Kahn / Troy Somatic / Alvin Zipursky / Claudio Sandoval / /
Position
‡Fisher / Fisher / /
ProvinceOrState
New York / /
Technology
Single Nucleotide Polymorphism / Neural Network / Biotechnology / http / SNP / html / Human Genome / /
NEOPLASIA Brief report Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome